

Our Founder/CEO/CSO, Sareina Wu, and our Director of Scientific Communication, Marcus Calkins, will present our work as invited speakers at the Advanced Therapies in Boston, US. (November 4-5, 2025)
Our team

GF-CART01 Clinical Milestone & GF-CART03 Solid Tumor Innovation Unveiled
2025-09-16GenomeFrontier Presents at 9th Annual CAR-TCR Summit Europe
2026-02-23

Our Founder/CEO/CSO, Sareina Wu, and our Director of Scientific Communication, Marcus Calkins, will present our work as invited speakers at the Advanced Therapies in Boston, US. (November 4-5, 2025)
Our team
